AmplifAI | $33,700,000 | (Sep 24, 2025)
RefAssured | $3,300,000 | (Sep 24, 2025)
Creem | $2,116,601 | (Sep 24, 2025)
Certified by Founder
Lodge
Apnimed
start up
United States
- Cambridge, Massachusetts
- 04/05/2022
- Series C
- $62,500,000
Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.
- Industry Pharmaceuticals
- Website https://apnimed.com/
- LinkedIn https://www.linkedin.com/company/apnimed/about/
Manas AI | $26,000,000 | (Sep 24, 2025)
Oriane | $1,500,000 | (Sep 24, 2025)
Duel Tech | $16,000,000 | (Sep 24, 2025)
Testkube | $8,000,000 | (Sep 24, 2025)
Obot AI | $35,000,000 | (Sep 24, 2025)
Pillar(ITALY) | $3,775,152 | (Sep 24, 2025)
Zealthix | $1,100,000 | (Sep 24, 2025)
Tilt(2) | $7,100,000 | (Sep 23, 2025)
DaltonTx | $5,402,820 | (Sep 23, 2025)